Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID

firstwordpharmaFebruary 23, 2019

Tag: ORCHARD THERAPEUTICS , Two-Year Follow-Up Data , ADA-SCID

PharmaSources Customer Service